Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation

BF Gage, AB Cardinalli, GW Albers, DK Owens - Jama, 1995 - jamanetwork.com
… However, for 75-year-old patients with NVAF alone, prescribing warfarin costwarfarin,
aspirin was preferred to no therapy on the basis of both quality-adjusted survival and cost in all …

Cost-effective prophylaxis against venous thromboembolism after total joint arthroplasty: warfarin versus aspirin

RM Tabatabaee, MR Rasouli, MG Maltenfort… - The Journal of …, 2015 - Elsevier
cost-effectiveness studies comparing aspirin and warfarin. In a Markov cohort cost-effectiveness
analysis, we found that aspirin cost … life-years (QALYs) than warfarin in all age groups. …

Cost effectiveness of warfarin versus aspirin in patients older than 75 years with atrial fibrillation

S Jowett, S Bryan, J Mant, K Fletcher, A Roalfe… - Stroke, 2011 - Am Heart Assoc
cost-effectiveness analysis conducted alongside the first randomized, controlled trial of warfarin
versus aspirin … The aim of this study was to determine the cost effectiveness of warfarin in …

[HTML][HTML] Cost-effectiveness of apixaban versus warfarin and aspirin in Sweden for stroke prevention in patients with atrial fibrillation

T Lanitis, T Kongnakorn, L Jacobson, A De Geer - Thrombosis research, 2014 - Elsevier
… Consequently, apixaban offers efficacy and safety advantages over warfarin and aspirin for
cost-effectiveness of apixaban compared with warfarin and apixaban compared with aspirin, …

Cost-effectiveness of warfarin: trial versus “real-world” stroke prevention in atrial fibrillation

SV Sorensen, S Dewilde, DE Singer, SZ Goldhaber… - American heart …, 2009 - Elsevier
… or neither warfarin nor aspirin.11, 12 Although aspirin is recommended … cost-effectiveness
of different treatment scenarios to identify the appropriate model framework to assess warfarin

[HTML][HTML] Cost effectiveness of apixaban versus warfarin or aspirin for stroke prevention in patients with atrial fibrillation: a Greek perspective

K Athanasakis, N Boubouchairopoulou… - American Journal of …, 2017 - Springer
… Our objective was to assess the cost effectiveness of apixaban, a direct acting oral anticoagulant
(DOAC), versus warfarin or aspirin for patients with AF in the Greek healthcare setting. …

Costeffectiveness of clopidogrel plus aspirin for stroke prevention in patients with atrial fibrillation in whom warfarin is unsuitable

CI Coleman, AD Straznitskas, DM Sobieraj… - The American journal of …, 2012 - Elsevier
costs, and costeffectiveness of adding clopidogrel to aspirin in patients with AF in whom
warfarin … that clopidogrel plus aspirin is cost effective compared to aspirin alone even at a lower …

Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation

JV Freeman, RP Zhu, DK Owens… - Annals of internal …, 2011 - acpjournals.org
cost-effective as an alternative to warfarin. Treatment seems to become less cost-effective
when daily costs … Medication costs for aspirin and warfarin included the range of discount and …

Cost-effectiveness of apixaban compared with aspirin for stroke prevention in atrial fibrillation among patients unsuitable for warfarin

S Lee, MW Anglade, J Meng, K Hagstrom… - … Quality and Outcomes, 2012 - Am Heart Assoc
… (AF) patients unsuitable for warfarin by 63% but does not … determine the cost-effectiveness
of apixaban versus aspirin. … cost-effective alternative to aspirin in patients whom warfarin

… in patients with atrial fibrillation in France: comparative cost-effectiveness of new oral anticoagulants (apixaban, dabigatran, and rivaroxaban), warfarin, and aspirin

T Lanitis, FE Cotté, AF Gaudin, I Kachaner… - Journal of medical …, 2014 - Taylor & Francis
… five treatment strategies including aspirin, dabigatran 110 mg… cost-effective alternative
vs warfarin with an incremental cost … incremental cost-effectiveness ratio (ICER) of €12,227/QALY. …